MapLight Therapeutics, Inc.
MPLT
$13.71
-$0.24-1.72%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -6.53% | -42.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.48% | -22.64% | |||
| Operating Income | 1.48% | 22.64% | |||
| Income Before Tax | 0.78% | 23.73% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.78% | 23.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.78% | 23.73% | |||
| EBIT | 1.48% | 22.64% | |||
| EBITDA | 1.46% | 22.70% | |||
| EPS Basic | 1.12% | 45.85% | |||
| Normalized Basic EPS | 2.43% | 46.10% | |||
| EPS Diluted | 1.12% | 45.85% | |||
| Normalized Diluted EPS | 2.43% | 46.10% | |||
| Average Basic Shares Outstanding | 0.34% | 40.83% | |||
| Average Diluted Shares Outstanding | 0.34% | 40.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||